​
​

Eton Pharmaceuticals (ETON) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Eton Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$31.64M

Latest Revenue (Q)

$10.32M

Main Segment (Y)

Product Sales and Royalties

Eton Pharmaceuticals Revenue by Period

Eton Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-48.90%
2022-12-31--2.66%
2021-12-31-55879.49%
2020-12-31--95.93%
2019-12-31-100.00%
2018-12-31--

Eton Pharmaceuticals generated $31.64M in revenue during NA 2023, up 48.90% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Eton Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-13.78%
2024-06-30-13.91%
2024-03-31-8.93%
2023-12-31-4.06%
2023-09-30--41.42%
2023-06-30-126.19%
2023-03-31--37.59%
2022-12-31-164.00%
2022-09-30--56.25%
2022-06-30-238.14%
2022-03-31--64.29%
2021-12-31-686.19%
2021-09-30--74.73%
2021-06-30--74.22%
2021-03-31-14587.65%
2020-12-31--150.31%
2020-09-30--905.00%
2020-06-30--79.80%
2020-03-31--78.43%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30--100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--

Eton Pharmaceuticals generated $10.32M in revenue during Q3 2024, up 13.78% compared to the previous quarter, and up 86.05% compared to the same period a year ago.

Eton Pharmaceuticals Revenue Breakdown

Eton Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 19
License----
Product Sales and Royalties----
Licensing Revenue----

Eton Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Sales and Royalties (82.62%), and License (17.38%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 22Jun 22Dec 21Jun 21Mar 21
Product Sales and Royalties-------
License-------
Licensing Revenue-------
Royalty Revenue-------

Eton Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product Sales and Royalties (95.16%), and License (4.84%).

Eton Pharmaceuticals Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Jun 22Dec 21Jun 21Mar 21
Licensing Revenue-----
Royalty Revenue-----

Eton Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 22: Licensing Revenue (100.00%).

Eton Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TVTXTravere Therapeutics--
ALECAlector--
ETONEton Pharmaceuticals--
TARSTarsus Pharmaceuticals--
KRONKronos Bio--
INBXInhibrx Biosciences--
LYRALyra Therapeutics--
LIANLianBio--
BDTXBlack Diamond Therapeutics--
ALDXAldeyra Therapeutics--
GOSSGossamer Bio--
CNTBConnect Biopharma--
ABOSAcumen Pharmaceuticals--
REPLReplimune Group--
PASGPassage Bio--
ELYMEliem Therapeutics--
CELCCelcuity--
MACKMerrimack Pharmaceuticals--
NVCTNuvectis Pharma--
ELVNEnliven Therapeutics--
NUVBNuvation Bio--
ELDNEledon Pharmaceuticals--

ETON Revenue FAQ

What is Eton Pharmaceuticals’s yearly revenue?

Eton Pharmaceuticals's yearly revenue for 2023 was $31.64M, representing an increase of 48.90% compared to 2022. The company's yearly revenue for 2022 was $21.25M, representing a decrease of -2.66% compared to 2021. ETON's yearly revenue for 2021 was $21.83M, representing an increase of 55879.49% compared to 2020.

What is Eton Pharmaceuticals’s quarterly revenue?

Eton Pharmaceuticals's quarterly revenue for Q3 2024 was $10.32M, a 13.78% increase from the previous quarter (Q2 2024), and a 46.90% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $9.07M, a 13.91% increase from the previous quarter (Q1 2024), and a -24.36% decrease year-over-year (Q2 2023). ETON's quarterly revenue for Q1 2024 was $7.97M, a 8.93% increase from the previous quarter (Q4 2023), and a 50.19% increase year-over-year (Q1 2023).

What is Eton Pharmaceuticals’s revenue growth rate?

Eton Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 44.93%, and for the last 5 years (2019-2023) was 3199.48%.

What are Eton Pharmaceuticals’s revenue streams?

Eton Pharmaceuticals's revenue streams in c 23 are License, and Product Sales and Royalties. License generated $5.5M in revenue, accounting 17.38% of the company's total revenue Product Sales and Royalties generated $26.14M in revenue, accounting 82.62% of the company's total revenue

What is Eton Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Eton Pharmaceuticals was Product Sales and Royalties. This segment made a revenue of $26.14M, representing 82.62% of the company's total revenue.